Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.18
+0.06 (0.74%)
At close: May 29, 2026, 4:00 PM EDT
8.17
-0.01 (-0.12%)
After-hours: May 29, 2026, 4:00 PM EDT
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees increased by 1 or 1.67% compared to the previous year.
Employees
61
Change (1Y)
1
Growth (1Y)
1.67%
Revenue / Employee
$85,279
Profits / Employee
-$4,633,016
Market Cap
300.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 1 | 1.67% | 61 | 0 |
| Dec 31, 2024 | 60 | -6 | -9.09% | 60 | 0 |
| Dec 31, 2023 | 66 | -9 | -12.00% | 66 | 0 |
| Dec 31, 2022 | 75 | 4 | 5.63% | 72 | 3 |
| Dec 31, 2021 | 71 | 9 | 14.52% | 69 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Nautilus Biotechnology | 127 |
| AC Immune | 122 |
| Niagen Bioscience | 117 |
| Silence Therapeutics | 88 |
| Editas Medicine | 87 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
ARMP News
- 15 days ago - Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year - TheFly
- 15 days ago - Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - PRNewsWire
- 22 days ago - Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02 - TheFly
- 22 days ago - Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 - PRNewsWire
- 25 days ago - Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" - PRNewsWire
- 4 weeks ago - Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. - PRNewsWire
- 7 weeks ago - Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch - TheFly
- 2 months ago - Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year - TheFly